Form 8-K - Current report:
SEC Accession No. 0001641172-25-023715
Filing Date
2025-08-14
Accepted
2025-08-14 07:30:34
Documents
15
Period of Report
2025-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38539
2 EX-99.1 ex99-1.htm EX-99.1 64896
3 GRAPHIC ex99-1_001.jpg GRAPHIC 14598
  Complete submission text file 0001641172-25-023715.txt   330271

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20250814.xsd EX-101.SCH 3044
5 XBRL DEFINITION FILE abeo-20250814_def.xml EX-101.DEF 26604
6 XBRL LABEL FILE abeo-20250814_lab.xml EX-101.LAB 34915
7 XBRL PRESENTATION FILE abeo-20250814_pre.xml EX-101.PRE 22808
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3833
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 251214353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)